[Experiments and clinical experience with cephalexin].
D000328:Adult; D000368:Aged; D001412:Bacillus subtilis / Q000187:drug effects; D002509:Cephaloridine / Q000494:pharmacology; D002511:Cephalosporins / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D003556:Cystitis / Q000188:drug therapy; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007239:Infections / Q000188:drug therapy; D008171:Lung Diseases / Q000188:drug therapy; D008175:Lung Neoplasms / Q000150:complications; D008297:Male; D008875:Middle Aged; D011511:Proteus / Q000187:drug effects; D011550:Pseudomonas aeruginosa / Q000187:drug effects; D012505:Sarcina / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects
D002511:Cephalosporins; D002509:Cephaloridine